committ

  1. T

    Acura Pharmaceuticals And King Pharmaceuticals Provide Update On FDA Advisory Committ

    Acura Pharmaceuticals, Inc. (Nasdaq: ACUR) and King Pharmaceuticals®, Inc. (NYSE: KG) announced that the U.S. Food and Drug Administration's (FDA) Anesthetic and Life Support Drugs and Drug Safety and Risk Management Committees voted that they do not have enough evidence to support the...
Back
Top